Thus, while HCK has a direct role in promoting some blood-derived cancers, its aberrant activation in innate immune cells of the tumor microenvironment facilitates tumorigenesis and enables progression in experimental models and in human cancers. The gene discussed is HCK; the disease is neoplasm.